EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The expanding clinical and genetic spectrum of DYNC1H1 -related disorders

Birk Möller, Lena-Luise Becker, Afshin Saffari, Alexandra Afenjar, Emanuele G Coci, Rachel Williamson, Catherine Ward-Melver, Marc Gibaud, Lucie Sedláčková, Petra Laššuthová, Zuzana Libá, Markéta Vlčková und 44 weitere

Brain · 2025

DOI: 10.1093/brain/awae183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Birk Möller und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Cytoplasmic Dyneins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Broad Institute of MIT and Harvard, NHGRI NIH HHS, German Society for Muscle Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracellular trafficking involves an intricate machinery of motor complexes, including the dynein complex, to shuttle cargo for autophagolysosomal degradation. Deficiency in dynein axonemal chains, as well as cytoplasmic light and intermediate chains, have been linked with ciliary dyskinesia and skeletal dysplasia. The cytoplasmic dynein 1 heavy chain protein (DYNC1H1) serves as a core complex for retrograde trafficking in neuronal axons. Dominant pathogenic variants in DYNC1H1 have been previously implicated in peripheral neuromuscular disorders (NMD) and neurodevelopmental disorders (NDD). As heavy-chain dynein is ubiquitously expressed, the apparent selectivity of heavy chain dyneinopathy for motor neuronal phenotypes remains currently unaccounted for. Here, we aimed to evaluate the full DYNC1H1-related clinical, molecular and imaging spectrum, including multisystem features and novel phenotypes presenting throughout life. We identified 47 cases from 43 families with pathogenic heterozygous variants in DYNC1H1 (aged 0–59 years) and collected phenotypic data via a comprehensive standardized survey and clinical follow-up appointments. Most patients presented with divergent and previously unrecognized neurological and multisystem features, leading to significant delays in genetic testing and establishing the correct diagnosis. Neurological phenotypes include novel autonomic features, previously rarely described behavioral disorders, movement disorders and periventricular lesions. Sensory neuropathy was identified in nine patients (median age of onset 10.6 years), of which five were only diagnosed after the second decade of life, and three had a progressive age-dependent sensory neuropathy. Novel multisystem features included primary immunodeficiency, bilateral sensorineural hearing loss, organ anomalies and skeletal manifestations, resembling the phenotypic spectrum of other dyneinopathies. We also identified an age-dependent biphasic disease course with developmental regression in the first decade and, following a period of stability, neurodegenerative progression after the second decade of life. Of note, we observed several cases in whom neurodegeneration appeared to be prompted by intercurrent systemic infections with double-stranded DNA viruses (Herpesviridae) or single-stranded RNA viruses (Ross River fever, SARS-CoV-2). Moreover, the disease course appeared to be exacerbated by viral infections regardless of age and/or severity of neurodevelopmental disorder manifestations, indicating a role of dynein in anti-viral immunity and neuronal health. In summary, our findings expand the clinical, imaging and molecular spectrum of pathogenic DYNC1H1 variants beyond motor neuropathy disorders and suggest a life-long continuum and age-related progression due to deficient intracellular trafficking. This study will facilitate early diagnosis and improve counselling and health surveillance of affected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytoplasmic DyneinsHumansAdultMaleChildAdolescentMiddle AgedFemaleChild, PreschoolYoung AdultInfantInfant, NewbornPhenotypeMutationNeurodevelopmental Disorders

Stichwörter der Autor:innen

autophagyintracellular traffickingneurodevelopmental disordersviral immunity

Substanzen

Cytoplasmic DyneinsDYNC1H1 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
  • Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Center for Chronically Sick Children, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Institute for Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Heidelberg University, Medical Faculty Heidelberg, University Hospital Heidelberg, Center for Pediatrics and Adolescent Medicine, Department of Pediatrics I, Division of Child Neurology and Metabolic Medicine, 69120 Hei…
  • Reference Center for Malformations and Congenital Diseases of the Cerebellum and Intellectual Disabilities of Rare Causes, Department of Genetics and Medical Embryology, Sorbonne University, Trousseau Hospital Paris, 75…

ORCID-Profile: Eric W Klee, Moritz Thiel, Erik-Jan Kamsteeg, Alan H Beggs, Anne Koy, Hormos Salimi Dafsari

Förderung

  • Broad Institute of MIT and Harvard
  • NHGRI NIH HHS
  • German Society for Muscle Diseases
  • NICHD NIH HHS
  • NEI NIH HHS
  • NHLBI NIH HHS
  • Ministry of Health of the Czech Republic
  • NINDS NIH HHS

Zitieren

APA

Möller, B., Becker, L. L., Saffari, A., Afenjar, A., Coci, E. G., Williamson, R., Ward-Melver, C., Gibaud, M., Sedláčková, L., Laššuthová, P., Libá, Z., Vlčková, M., William, N., Klee, E. W., Gavrilova, R. H., Lévy, J., Capri, Y., Scavina, M., Körner, R. W., …, & Dafsari, H. S. (2025). The expanding clinical and genetic spectrum of DYNC1H1 -related disorders. Brain. https://doi.org/10.1093/brain/awae183

Vancouver

Möller B, Becker LL, Saffari A, Afenjar A, Coci EG, Williamson R, et al. The expanding clinical and genetic spectrum of DYNC1H1 -related disorders. Brain. 2025. doi:10.1093/brain/awae183

BibTeX
@article{Mller2025,
  author = {Möller, Birk and Becker, Lena-Luise and Saffari, Afshin and Afenjar, Alexandra and Coci, Emanuele G and Williamson, Rachel and Ward-Melver, Catherine and Gibaud, Marc and Sedláčková, Lucie and Laššuthová, Petra and Libá, Zuzana and Vlčková, Markéta and William, Nancy and Klee, Eric W and Gavrilova, Ralitza H and Lévy, Jonathan and Capri, Yline and Scavina, Mena and Körner, Robert Walter and Valivullah, Zaheer and Weiß, Claudia and Möller, Greta Marit and Frazier, Zoë and Roberts, Amy and Gener, Blanca and Scala, Marcello and Striano, Pasquale and Zara, Federico and Thiel, Moritz and Sinnema, Margje and Kamsteeg, Erik-Jan and Donkervoort, Sandra and Duboc, Veronique and Zaafrane-Khachnaoui, Khaoula and Elkhateeb, Nour and Selim, Laila and Margot, Henri and Marin, Victor and Beneteau, Claire and Isidor, Bertrand and Cogne, Benjamin and Keren, Boris and Küsters, Benno and Beggs, Alan H and Sveden, Abigail and Chopra, Maya and Genetti, Casie A and Nicolai, Joost and Dötsch, Jörg and Koy, Anne and Bönnemann, Carsten G and von der Hagen, Maja and von Kleist-Retzow, Jürgen-Christoph and Voermans, Nicol C and Jungbluth, Heinz and Dafsari, Hormos Salimi},
  title = {The expanding clinical and genetic spectrum of DYNC1H1 -related disorders},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awae183}
}
Kostenlos starten →